Reduction of ethanol consumption in alcohol-preferring rats by dual expression gene transfer

Alcohol and Alcoholism

Volumn 47, Issue 2, 2012, Pages 102-108

  Rivera Meza, Mario ^a   Quintanilla, María Elena ^a   Tampier, Lutske ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ADENOVIRUS VECTOR; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; COMPLEMENTARY RNA;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISENSE THERAPY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ACETALDEHYDE; ADENOVIRIDAE; ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; ALCOHOLISM; ALDEHYDE DEHYDROGENASE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; ISOENZYMES; LIVER; MITOCHONDRIAL PROTEINS; RATS; RATS, WISTAR; RNA, ANTISENSE;

ANIMALIA; RATTUS;

EID: 84857683795     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr161     Document Type: Article

References (47)

1. Anton RF, O'Malley SS, Ciraulo DA et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-17.
2. Brunetti-Pierri N, Ng P (2011) Helper-dependent adenoviral vectors for liver-directed gene therapy. Hum Mol Genet 20(R1):R7-13.
3. Brunetti-Pierri N, Stapleton GE, Law M et al. (2009) Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol Ther 17:327-33.
4. Chambers GK, Marshall SJ, Robinson GM et al. (2002) The genetics of alcoholism in Polynesians: alcohol and aldehyde dehydrogenase genotypes in young men. Alcohol Clin Exp Res 26:949-55.
5. Chen CC, Lu RB, Chen YC et al. (1999) Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet 65:795-807.
6. Chen YJ, Chen C, Wu D et al. (2006) Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks. Int J Cancer 119:2827-31.
7. Chen YC, Peng GS, Wang MF et al. (2009a) Polymorphism of ethanol-metabolism genes and alcoholism: correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences. Chem Biol Interact 178:2-7.
8. Chen YC, Peng GS, Tsao TP et al. (2009b) Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics 19:588-99.
9. Ducci F, Goldman D (2008) Genetic approaches to addiction: genes and alcohol. Addiction 103:1414-28.
10. Fuller R (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99:21-4.
11. Garver E, Tu GC, Cao QN et al. (2001) Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism result in an aversion to ethanol. J Exp Med 5:571-80.
12. He TC, Zhou S, Da Costa LT et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci 95:2509-14.
13. Heath AC, Meyer J, Jardine R et al. (1991) The inheritance of alcohol consumption patterns in a general population twin sample: II. Determinants of consumption frequency and quantity consumed. J Stud Alcohol 52:425-33.
14. Higuchi S (1994) Polymorphisms of ethanol metabolizing enzyme genes and alcoholism. Alcohol Alcohol Suppl 2:29-34.
15. Hurley TD, Edenberg HJ, Bosron WF (1990) Expression and kinetic characterization of variants of human β1β1 alcohol dehydrogenase containing substitutions at amino acid 47. J Biol Chem 265:16366-72.
16. Hurley TD, Bosron WF, Hamilton JA et al. (1991) Structure of human β1β1 alcohol dehydrogenase: catalytic effects of non-active-site substitutions. Proc Natl Acad Sci 88:8149-53.
17. Israel Y, Rivera-Meza M, Quintanilla ME et al. (2011) Acetaldehyde burst protection of ADH1B*2 against alcoholism: an additional hormesis protection against esophageal cancers following alcohol consumption? Alcohol Clin Exp Res 35:806-10.
18. Johnson BA (2008) Update on neuropharmacological treatments of alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75:34-56.
19. Karahanian E, Ocaranza P, Israel Y (2005) Aldehyde dehydrogenase (ALDH2) activity in hepatoma cells is reduced by an adenoviral vector coding for an ALDH2 antisense mRNA. Alcohol Clin Exp Res 29:1384-9.
20. Karahanian E, Quintanilla ME, Tampier L et al. (2011) Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res 35:606-12.
21. Kim IH, Józkowicz A, Piedra PA et al. (2001) Lifetime correction of genetic deficiency in mice with a single injection of helperdependent adenoviral vector. PNAS 98:13282-7.
22. Kim DJ, Choi IG, Park BL et al. (2008) Major genetic components underlying alcoholism in Korean population. Hum Mol Genet 17:854-8.
23. Kranzler HR, Van Kirk J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 25:1335-41.
24. Lozier JN, Czako G, Mondoro TH et al. (2002) Toxicity of a firstgeneration adenoviral vector in rhesus macaques. Hum Gene Ther 13:113-24.
25. Mardones J, Segovia-Riquelme N (1983) Thirty-two years of selection of rats by ethanol preference: UChA and UChB strains. Neurobehav Toxicol Teratol 5:171-8.
26. Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70:7498-509.
27. Mizoi Y, Yamamoto K, Ueno Y et al. (1994) Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variations of alcohol metabolism. Alcohol Alcohol 29:707-10.
28. Morrisey RE, Horvath C, Snyder EA et al. (2002) Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene. Toxicol Sci 65:266-75.
29. Ocaranza P, Quintanilla ME, Tampier L et al. (2008) Gene therapy reduces ethanol intake in an animal model of alcohol dependence. Alcohol Clin Exp Res 32:52-7.
30. Peng GS, Chen YC, Tsao TP et al. (2007) Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics 17:845-55.
31. Prescott CA, Kendler KS (1999) Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 156:34-40.
32. Quantin B, Perricaudet LD, Tajbakhsh S et al. (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci 89:2581-4.
33. Quintanilla ME, Israel Y, Sapag A et al. (2006) The UChA and UChB rat lines: metabolic and genetic differences influencing ethanol intake. Addict Biol 11:310-23.
34. Quintanilla ME, Tampier L, Sapag A et al. (2007) Sex differences, alcohol dehydrogenase, acetaldehyde burst, and aversion to ethanol in the rat: a systems perspective. Am J Physiol Endocrinol Metab 293:531-7.
35. Quintanilla ME, Tampier L, Karahanian E et al. (2011) Reward and relapse: complete gene-induced dissociation in an animal model of alcohol dependence. Alcohol Clin Exp Res [Epub ahead of print].
36. Raper SE, Chirmule N, Lee FS et al. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148-58.
37. Reddy PS, Sakhuja K, Ganesh S et al. (2002) Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol Ther 5:63-73.
38. Rehm J, Taylor B, Room R (2006) Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 25:503-13.
39. Rivera-Meza M, Quintanilla ME, Tampier L et al. (2010) Mechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model. FASEB J 24:266-74.
40. Smith JS, Tian J, Muller J et al. (2004) Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease. Gene Ther 11:431-8.
41. Tampier L, Quintanilla ME, Israel Y (2008) Tolerance to disulfiram by chronic alcohol intake in the rat. Alcohol Clin Exp Res 32:937-41.
42. Thomasson HR, Edenberg HJ, Crabb DW et al. (1991) Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 48:677-81.
43. Toietta G, Mane VP, Norona WS et al. (2005) Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci 102:3930-5.
44. Tu GC, Israel Y (1995) Alcohol consumption by Orientals in North America is predicted largely by a single gene. Behav Genet 25:59-65.
45. World Health Organization (2009) Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: WHO Press.
46. Yang Y, Nunes FA, Berencsi K et al. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci 91:4407-11.
47. Zintzaras E, Stefanidis I, Santos M et al. (2006) Do alcoholmetabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43:352-61.